Shoulder pain drug trial halted early
NCT ID NCT05722522
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether the drug secukinumab could reduce pain and improve function in adults with moderate to severe rotator cuff tendinopathy, a common shoulder condition. Participants received either the drug or a placebo for 24 weeks. The trial was terminated early, and results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ROTATOR CUFF TENDINOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Healthy Life Research
Miami, Florida, 33184, United States
-
IRIS Research and Development
Plantation, Florida, 33324, United States
-
Millennium Clinical Trials
Westlake Village, California, 91361, United States
-
Novartis Investigative Site
San Miguel Tucuman, Tucumán Province, 4000, Argentina
-
Novartis Investigative Site
Buenos Aires, C1114AAP, Argentina
-
Novartis Investigative Site
San Miguel de Tucumán, 4000, Argentina
-
Novartis Investigative Site
Sofia, 1336, Bulgaria
-
Novartis Investigative Site
Québec, Quebec, G1V 3M7, Canada
-
Novartis Investigative Site
Brno, Czech Republic, 66250, Czechia
-
Novartis Investigative Site
Kolín, 280 02, Czechia
-
Novartis Investigative Site
Kota Kinabalu, Sabah, 88300, Malaysia
-
Novartis Investigative Site
Ponte de Lima, 4990-041, Portugal
-
Precision Clinical Research LLC
Sunrise, Florida, 33351, United States
-
West Clinical Research
Morehead City, North Carolina, 28557, United States
-
West Tennessee Research Institute
Jackson, Tennessee, 38305, United States